FIM
SVA

Freedom Investment Management’s Sinovac Biotech, Ltd SVA Stock Holding History

Freedom Investment Management’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,029
Closed – – 820
2022
Q3 		$0 Sell
17,029
-23
-0.1% – ﹤0.01% 804
2022
Q2 		$0 Sell
17,052
-168
-1% – ﹤0.01% 865
2022
Q1 		$111K Sell
17,220
-165
-0.9% -$1.06K 0.01% 741
2021
Q4 		$112K Sell
17,385
-354
-2% -$2.28K 0.01% 834
2021
Q3 		$115K Sell
17,739
-140
-0.8% -$908 0.01% 789
2021
Q2 		$116K Sell
17,879
-17,019
-49% -$110K 0.01% 847
2021
Q1 		$117K Buy
34,898
+16,526
+90% +$55.4K 0.01% 815
2020
Q4 		$119K Sell
18,372
-341
-2% -$2.21K 0.01% 595
2020
Q3 		$121K Sell
18,713
-1,913
-9% -$12.4K 0.01% 526
2020
Q2 		$133K Sell
20,626
-65
-0.3% -$419 0.01% 531
2020
Q1 		$134K Sell
20,691
-7
-0% -$45 0.01% 637
2019
Q4 		$134K Sell
20,698
-29
-0.1% -$188 0.01% 638
2019
Q3 		$134K Sell
20,727
-32
-0.2% -$207 0.01% 653
2019
Q2 		$134K Sell
20,759
-92
-0.4% -$594 0.01% 654
2019
Q1 		$135K Sell
20,851
-20,882
-50% -$137K 0.01% 651
2018
Q4 		$290K Sell
41,733
-2,169
-5% -$15.8K 0.02% 593
2018
Q3 		$302K Buy
43,902
+2,074
+5% +$15K 0.02% 698
2018
Q2 		$312K Sell
41,828
-117,165
-74% -$922K 0.02% 744
2018
Q1 		$1.37M Buy
158,993
+2,501
+2% +$20.6K 0.07% 281
2017
Q4 		$1.23M Buy
156,492
+6,953
+5% +$52K 0.06% 284
2017
Q3 		$1.05M Sell
149,539
-7,240
-5% -$49.4K 0.06% 319
2017
Q2 		$1.06M Buy
156,779
+983
+0.6% +$5.39K 0.06% 292
2017
Q1 		$893K Sell
155,796
-19,170
-11% -$111K 0.05% 333
2016
Q4 		$1.03M Sell
174,966
-46,645
-21% -$281K 0.06% 233
2016
Q3 		$1.31M Sell
221,611
-6,739
-3% -$39.6K 0.08% 171
2016
Q2 		$1.35M Buy
228,350
+9,794
+4% +$60K 0.09% 141
2016
Q1 		$1.4M Sell
218,556
-22,118
-9% -$133K 0.1% 143
2015
Q4 		$1.38M Buy
240,674
+237,012
+6,472% +$1.28M 0.1% 145
2015
Q3 		$418K Sell
3,662
-153,633
-98% -$814K 0.04% 366
2015
Q2 		$826K Buy
157,295
+45,549
+41% +$241K 0.08% 200
2015
Q1 		$554K Buy
111,746
+55,227
+98% +$272K 0.06% 270
2014
Q4 		$296K Buy
56,519
+34,761
+160% +$177K 0.04% 425
2014
Q3 		$105K Buy
+21,758
New +$117K 0.02% 477

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Freedom Investment Management's SVA Position: Q4 2022 in Review

Freedom Investment Management sold out of Sinovac Biotech, Ltd (SVA) in Q4 2022, closing a stake of 17,029 shares.

Freedom Investment Management first reported a position in SVA in Q3 2014 and held it in 33 quarters. The position peaked at $1.4M in Q1 2016. 9 funds tracked by Wall St. Rank hold SVA as of Q4 2022.

  • Freedom Investment Management reported no remaining Sinovac Biotech, Ltd position as of Q4 2022 after selling out during the quarter.
  • Freedom Investment Management sold 17,029 Sinovac Biotech, Ltd shares in Q4 2022.
  • Freedom Investment Management first reported a position in Sinovac Biotech, Ltd in Q3 2014 and held it in 33 quarters.
  • Freedom Investment Management's Sinovac Biotech, Ltd position peaked at $1.4M in Q1 2016.
  • 9 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2022.

Based on Freedom Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.